3 employees
Macrobian-Biotech aims at performing clinical research and treatments for disorders affecting the dopamine system.
2017
Macrobian-Biotech raised undisclosed on May 15, 2017
Investors: UvA AMC HvA Ventures Holding BV
Macrobian-Biotech raised undisclosed on February 1, 2017
Investors: Amsterdam Center for Entrepreneurship